List of insiders holdings for Neurogene Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 2024-11-27 16:39:29 | 0 1,717,127 | 1,717,127 | Form 4 |
| 2 | Redmile Group LLC Green Jeremy 10% Owner | 2026-02-17 16:16:08 | 1,557,179 0 | 1,557,179 | Form 13G |
| 3 | McMinn Rachel Chief Executive Officer | 2026-02-24 18:48:26 | 1,502,759 0 | 1,502,759 | Form 4 |
| 4 | Ventures West 8 Limited Partnership 10% Owner | 2016-02-16 15:21:10 | 1,020,430 0 | 1,020,430 | Form 13G |
| 5 | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 2025-08-14 16:27:25 | 991,804 0 | 991,804 | Form 13G |
| 6 | PFIZER INC 10% Owner | 2015-08-18 17:05:42 | 481,529 0 | 481,529 | Form 13G |
| 7 | Main David President and CEO | 2018-08-09 19:07:07 | 415,000 0 | 415,000 | Form 4 |
| 8 | DRACHMAN JONATHAN G President and CEO | 2022-08-04 16:38:51 | 350,000 0 | 350,000 | Form 4 |
| 9 | Alam Kamran CFO, Vice President Finance | 2018-08-09 19:03:08 | 195,000 0 | 195,000 | Form 4 |
| 10 | Walkey Carl Senior Vice President | 2022-08-04 16:43:37 | 150,000 0 | 150,000 | Form 4 |
| 11 | MacKenzie Lloyd Chief Operating Officer | 2018-08-09 19:04:32 | 145,000 0 | 145,000 | Form 4 |
| 12 | Cvijic Christine Mikail President and CFO | 2026-03-17 18:01:02 | 105,798 0 | 105,798 | Form 4 |
| 13 | Vance Holly General Counsel | 2021-08-05 16:25:06 | 100,000 0 | 100,000 | Form 4 |
| 14 | Cochener Donna General Counsel, SVP Legal | 2022-08-04 16:37:38 | 100,000 0 | 100,000 | Form 4 |
| 15 | McCloskey Shelley VP, HR and Administration | 2018-08-09 19:05:37 | 75,000 0 | 75,000 | Form 4 |
| 16 | Jenkins Abigail Chief Commercial Officer | 2018-03-13 16:53:32 | 75,000 0 | 75,000 | Form 4 |
| 17 | Troupin Barbara Chief Medical Officer | 2018-03-13 17:04:31 | 75,000 0 | 75,000 | Form 4 |
| 18 | Ho Robert Chief Financial Officer | 2022-02-02 16:36:59 | 70,000 0 | 70,000 | Form 4 |
| 19 | Jordan Julie Chief Medical Officer | 2026-02-24 18:49:24 | 42,900 0 | 42,900 | Form 4 |
| 20 | Patel Priti Former Chief Medical Officer | 2023-04-04 20:51:03 | 37,313 0 | 37,313 | Form 4 |
| 21 | SHREWSBURY STEPHEN B CMO; Senior VP Clinical Dev. | 2016-03-14 17:42:11 | 35,000 0 | 35,000 | Form 4 |
| 22 | Cobb Stuart Chief Scientific Officer | 2026-03-17 18:01:47 | 30,497 0 | 30,497 | Form 4 |
| 23 | Williams Lewis T Director | 2021-05-13 17:39:26 | 25,000 0 | 25,000 | Form 4 |
| 24 | Mitchell David Chilton VP Global Regulatory & Quality | 2017-03-10 21:20:07 | 25,000 0 | 25,000 | Form 4 |
| 25 | SIMPSON TODD E Director | 2023-06-09 16:28:18 | 25,000 0 | 25,000 | Form 4 |
| 26 | Lavelle Erin Director | 2023-06-09 16:25:32 | 25,000 0 | 25,000 | Form 4 |
| 27 | Babler Martin Director | 2023-06-09 16:24:41 | 25,000 0 | 25,000 | Form 4 |
| 28 | Nolan Sean P. Director | 2020-05-07 16:25:33 | 25,000 0 | 25,000 | Form 4 |
| 29 | Lavelle Erin M. Director | 2021-05-13 17:37:13 | 25,000 0 | 25,000 | Form 4 |
| 30 | Smith Sean Michael Interim CFO, Prin Acct Off | 2023-08-14 16:06:55 | 21,637 0 | 21,637 | Form 4 |
| 31 | Bridger Gary Director | 2018-05-09 18:15:59 | 15,000 0 | 15,000 | Form 4 |
| 32 | Pelzer Robert Director | 2018-05-09 18:17:37 | 15,000 0 | 15,000 | Form 4 |
| 33 | PALEKAR ROHAN Director | 2026-02-24 18:48:05 | 12,050 0 | 12,050 | Form 4 |
| 34 | Woods Robert Keith Director | 2025-06-13 12:07:13 | 12,050 0 | 12,050 | Form 4 |
| 35 | Woods Keith Director | 2026-02-24 18:40:02 | 12,050 0 | 12,050 | Form 4 |
| 36 | Freedland Cory S. Director | 2026-02-24 18:40:27 | 12,050 0 | 12,050 | Form 4 |
| 37 | Noonberg Sarah B. Director | 2026-02-24 18:40:45 | 12,050 0 | 12,050 | Form 4 |
| 38 | BAFFI ROBERT Director | 2026-02-24 18:41:39 | 12,050 0 | 12,050 | Form 4 |
| 39 | Neu Kelvin Director | 2017-03-27 18:07:32 | 36 0 | 36 | Form 3 |
| 40 | Jones Elaine V Director | 2014-03-06 17:25:34 | 0 0 | 0 | Form 3 |
| 41 | Boyd Meta Cantey Director | 2019-08-23 15:58:29 | 0 0 | 0 | Form 3 |
| 42 | Levy Richard S Director | 2017-03-27 17:04:42 | 0 0 | 0 | Form 3 |
| 43 | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2016-02-12 15:19:26 | 0 0 | 0 | Form 13G |
| 44 | LEVITT DANIEL J Director | 2018-05-16 19:45:26 | 0 0 | 0 | Form 4 |